Gyre Therapeutics, Inc. Common Stock (GYRE) is a publicly traded Healthcare sector company. As of July 16, 2026, GYRE trades at $6.28 with a market cap of $731.37M and a P/E ratio of 106.35. GYRE moved -2.44% today. Year to date, GYRE is -9.07%; over the trailing twelve months it is -13.36%. Its 52-week range spans $5.44 to $14.42. Analyst consensus is buy with an average price target of $19.00. Rallies surfaces GYRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for GYRE shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $6.28 |
| Market Cap | $731.37M |
| P/E Ratio | 106.35 |
| EPS | $0.06 |
| Dividend Yield | 0.24% |
| 52-Week High | $14.42 |
| 52-Week Low | $5.44 |
| Volume | 26.26K |
| Avg Volume | 0 |
| Revenue (TTM) | $116.59M |
| Net Income | $9.88M |
| Gross Margin | 95.36% |
2 analysts cover GYRE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.00.